Total US investment in health-related research grew a modest 4.2% from 2005 to 2006, significantly slower than the 6.8% increase in health costs, according to a report released by Research!America, a not-for-profit public education and advocacy alliance. The country spent approximately $116.0 billion last year on research to find new ways to treat, cure and prevent disease and disability. This represents a decrease relative to total health costs. For every dollar spent on health overall, $0.055 went to research in 2006, the smallest portion since 2001. This decline continues a trend that started in 2005, following a flattening in federal research spending that began in 2004, the report states.
Industry spending on R&D, which has for several years exceeded federal sources, increased only slightly from $61.0 billion in 2005 to $64.5 billion in 2006. However, this growth is overshadowed by the fact that a leveling out of public funding has in the past led to a similar stagnation in private funding, says Research!America.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze